|
|
Volumn 90, Issue 9, 1998, Pages 647-648
|
|
Breast Cancer Prevention Trial shows major benefit, some risk.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIESTROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
TAMOXIFEN;
ADULT;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
FEMALE;
FRACTURE;
HEALTH CARE ORGANIZATION;
HUMAN;
INCIDENCE;
POSTMENOPAUSE OSTEOPOROSIS;
RANDOMIZED CONTROLLED TRIAL;
RISK;
UNITED STATES;
ADULT;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CORONARY DISEASE;
ESTROGEN ANTAGONISTS;
FEMALE;
FRACTURES, BONE;
HUMANS;
INCIDENCE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
OSTEOPOROSIS, POSTMENOPAUSAL;
RANDOMIZED CONTROLLED TRIALS;
RISK;
TAMOXIFEN;
UNITED STATES;
|
|
EID: 0032490068
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/90.9.647 Document Type: Article |
|
Times cited : (28)
|
|
References (0)
|
